131 results
Page 2 of 7
8-K
EX-99.2
zppboygajf5wpc
15 May 23
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
lnqrgfvr g2
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
mf1vllprgt6
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-1.1
wj4x4jnsvp24vtjuu 9k
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
vwbi9dkc33e l43
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
sjkgmm2cwwkgsxxlnj
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
y1igpfd56w9ci e2gs
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
3ny1m2nd
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
349dqa dx
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am